| 摘要 |
The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies. |
| 申请人 |
ONCOTHERAPY SCIENCE, INC.;SHIBA, YASUHIRO;YOSHIOKA, HIROKI;YAMAMOTO, SHINJI;KUDO, AIKO;OHSAWA, RYUJI;NG, POHSING;NAKAMURA, YUSUKE;ENDO, KEIGO |
发明人 |
SHIBA, YASUHIRO;YOSHIOKA, HIROKI;YAMAMOTO, SHINJI;KUDO, AIKO;OHSAWA, RYUJI;NG, POHSING;NAKAMURA, YUSUKE;ENDO, KEIGO |
